TREX1 and neoplasm: Indeed, TREX1 is an upstream regulator of radiation-driven anti-tumor immunity (Vanpouille-Box et al., 2017) and STING is essential to promote tumor rejection in immunocompetent mice treated with the anticancer agent Topotecan (Kitai et al., 2017).